Sequencio presents cancer vaccine research at AACR meeting
April 01, 2026 | 15:09
The CK Life Sciences subsidiary showcased therapeutic immunotherapy development progress at the Philadelphia oncology conference.
CK Life Sciences forms Sequencio for cancer vaccine development
March 11, 2026 | 10:43
The Hong Kong biotechnology company created a subsidiary focused on researching and commercializing therapeutic immunotherapy products for oncology.
Mobile Version